Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188443 | SCV000242057 | uncertain significance | not provided | 2013-07-17 | criteria provided, single submitter | clinical testing | p.Gly335Cys (GGC>TGC): c.1003 G>T in exon 11 of the PNKP gene (NM_007254.2) The Gly335Cys missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The amino acid substitution is non-conservative, as a non-polar Glycine residue is replaced by a polar Cysteine residue, and the gain of a Cysteine may affect disulfide bond formation in the protein. However, it alters a poorly conserved position in the protein, and multiple in silico algorithms predict it may be benign. Therefore, based on the currently available information, it is unclear whether Gly335Cys is a disease-causing mutation or a rare benign variant.The variant is found in EPILEPSY panel(s). |
Fulgent Genetics, |
RCV000765463 | SCV000896754 | uncertain significance | Microcephaly, seizures, and developmental delay; Ataxia - oculomotor apraxia type 4 | 2018-10-31 | criteria provided, single submitter | clinical testing |